Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

TOVX holding history

Theriva Biologics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TOVX overviewAll 13F holders of TOVXFull Q2 2026 holdings

Shares (Q2 2026)
294,021
Value
$73.6K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of TOVX by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026294,021$73.6K<0.1%−156,242−34.7%ReducedHolders
Q1 2026450,263$88.2K<0.1%+238,176+112.3%AddedHolders
Q4 2025212,087$44.6K<0.1%+183,878+651.8%AddedHolders
Q3 202528,209$11.4K<0.1%+9,608+51.7%AddedHolders
Q2 202518,601$8.07K<0.1%−82−0.4%ReducedHolders
Q1 202518,683$20.6K<0.1%+18,683NewHolders
Q3 20240$00.0%−141,168−100.0%Sold outHolders
Q2 2024141,168$33.4K<0.1%00.0%UnchangedHolders
Q1 2024141,168$66.2K<0.1%00.0%UnchangedHolders
Q4 2023141,168$60.7K<0.1%00.0%UnchangedHolders
Q3 2023141,168$76.2K<0.1%+24,867+21.4%AddedHolders
Q2 2023116,301$116.3K<0.1%00.0%UnchangedHolders
Q1 2023116,301$81.2K<0.1%00.0%UnchangedHolders
Q4 2022116,301$52.0K<0.1%−280−0.2%ReducedHolders
Q3 2022116,581$114.0K<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q2 20221,165,836$248.0K<0.1%+37,715+3.3%AddedHolders
Q1 20221,128,121$321.0K<0.1%+151,805+15.5%AddedHolders
Q4 2021976,316$265.0K<0.1%00.0%UnchangedHolders
Q3 2021976,316$448.0K<0.1%+20,035+2.1%AddedHolders
Q2 2021956,281$576.0K<0.1%+95,863+11.1%AddedHolders
Q1 2021860,418$586.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.